In one tiny town, more than a dozen people were diagnosed with the rare neurodegenerative disease ALS. Why? I n March 2009, ...

Equities researchers at StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ ...

Public safety officers from across West Michigan held a charity hockey game on Saturday to raise awareness and funds for ...

A patient who sustained aphasia due to amyotrophic lateral sclerosis has regained the ability to communicate after receiving a brain-machine interface implant, a hospital in Beijing announced on ...

A group of researchers from University of Queensland, Queensland Brain Institute, Brisbane, Australia, have found out that ultrasound technology therapy potentially can boost cognitive function of the ...

Neurizon Therapeutics (ASX:NUZ) has shared an update on its preparations for its HEALEY ALS Platform Trial – a multicentre, ...

UCLA Health researchers say study findings uncover Huntington's disease mechanisms and pave new ways to develop treatments.

Cognixion is recruiting adults with ALS for a clinical trial testing BCI headset ONE Axon-R as a communication aid.

Four serum neurofilament light chain tests show high accuracy in diagnosing ALS and predicting its progression, new research suggests.

Cognixion's Axon-R headset is a device designed to read brain activity using EEG as a direct input for controls. Using brain responses as inputs, the tech is looking to give back communication to ...

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...